UK Man Without Human Heart Leaves Papworth Hospital with New Donor Heart
London Father Takes Family on Holiday to Celebrate Life with His New Human Heart
TUCSON, Ariz. – Sept. 10, 2013 – SynCardia Systems, Inc. (www.syncardia.com), announced today that Matthew Green, the UK’s 1st patient to be discharged with the SynCardia temporary Total Artificial Heart, has been successfully bridged to transplant after almost two years of support.
Green, his wife and their 7-year-old son celebrated his new beginning with a holiday.
“I feel incredibly lucky that I have been given a third lease of life as a result of my heart transplant,” Green, 42, said recently. “It’s hard to put into words the gratitude I feel to my donor and their family. They have helped me to turn my life around again.”
Green, a pharmaceutical consultant from London, suffered from arrhythmogenic right ventricular cardiomyopathy (ARVC), a heart muscle disease that results in arrhythmia, heart failure and sudden death. Back in the late spring of 2011, Green’s heart condition became critical. “By the time I was admitted to the hospital, I was struggling to walk even a few yards,” he recalled.
"Matthew's condition was deteriorating rapidly and we discussed with him the possibility of receiving this device, because without it he may not have survived the wait until a suitable donor heart could be found for him," said Steven Tsui, Consultant Cardiothoracic Surgeon and Director of Transplant Service at Papworth Hospital. "The operation went extremely well."
Green received his Total Artificial Heart on June 9, 2011. He was discharged less than 2 months later, using the Freedom® portable driver, the world’s first wearable power supply for the SynCardia Total Artificial Heart. “Before the operation my heart beat was very weak and I could hardly feel my pulse,” he said. “And now (with the Total Artificial Heart) it’s a very strong heartbeat.”
Delighted with his new human heart, Green noted that the artificial heart “kept me going” as he waited for his transplant.
The Total Artificial Heart, powered by the Freedom portable driver, allowed Green to live at home while waiting for a suitable heart donor. He went on outings, including eating at restaurants, while the Freedom driver, carried in a shoulder bag, powered the artificial heart’s pumping mechanism with precisely calibrated pulses of air and vacuum.
Papworth Hospital is the first and only hospital in the UK certified to implant the SynCardia's Total Artificial Heart. Papworth performed the UK's first heart transplant in 1979 and has been using mechanical devices to support patients with end-stage heart failure since the 1980s.
The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
›› View TV News Summer 2011, Transplant patient takes heart from pioneering surgery Video Reuters
›› Read News Coverage Summer 2013, Matthew Green’s heart transplant
›› Read News Coverage Summer 2011, Papworth’s 1st Total Artificial Heart patient discharged
›› Read press release Summer 2011, Papworth Hospital
CAUTION - The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463